Volume 13, Issue 6 (November 2011) 13, 783–784; 10.1038/aja.2011.120

Stromal targeted therapy in bone metastatic prostate cancer: promise delivered

Oliver Sartor¹, William Goeckeler² and Oyvind Bruland³

1 Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA
2 Whitehouse Station, NJ 08889, USA
3 Faculty of Medicine, University of Oslo and Department of Oncology, Norwegian Radium Hospital, Oslo 0310, Norway

Correspondence: Dr O Sartor, (osartor@tulane.edu)